Tharimmune, Inc.

New Filing
CIK: 0001861657·Biotechnology·DELAWARE·Filed: Jul 7, 2025
Total Offering

$2,500,000

Amount Sold

$2,500,000

Investors

30

First Sale

Jun 13, 2025

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Sireesh Appajosyula
Related Person
Vincent LoPriore
Related Person
Sanam Parikh
Related Person
Clay Kahler
Related Person
Gary Stetz
Related Person
James Gordon Liddy
Related Person

Company

Canton Strategic Holdings, Inc.

34 SHREWSBURY AVENUE

RED BANK, NJ, 07701

(732) 889-3111

SEC Filing

0001641172-25-018011

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Tharimmune, Inc. Form D Filing — $2,500,000 | FilingFlow